Synchron’s Switch technology is implanted through blood vessels in the brain and designed to allow patients with limited or no mobility to operate computers with their minds. So far, the technology has been used by three patients in the U.S. and four in Australia.
In December, the company received $75 million in series C financing led by Arch Venture Partners.
Bezos Expeditions and Gates Frontier participated in the round that brought the company’s total capital raised to $145 million.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.